Using surface electromyography to predict recovery of arm function after stroke
Use of Surface Electromyography as a Tools to Predict Upper Extremity Recovery Function After Stroke
Universitas Padjadjaran · NCT06574737
This study is testing if measuring electrical signals from arm muscles can help predict how well stroke patients will recover their arm function.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Universitas Padjadjaran (other) |
| Locations | 1 site (Bandung, West Java) |
| Trial ID | NCT06574737 on ClinicalTrials.gov |
What this trial studies
This observational study aims to determine if surface electromyography (sEMG) can predict upper extremity recovery in stroke patients. It will analyze muscle electrical signals from the anterior deltoid, biceps, triceps, and wrist muscles, alongside manual muscle tests and Fugl-Meyer assessments. Conducted at HasanSadikin Hospital, the study will recruit hospitalized patients with acute upper extremity weakness due to stroke. The goal is to establish a correlation between sEMG parameters and motor function recovery outcomes.
Who should consider this trial
Good fit: Ideal candidates are hospitalized adults over 18 with acute upper extremity weakness due to stroke confirmed by imaging.
Not a fit: Patients with cognitive impairment, unstable medical conditions, or other neurological disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a reliable method for predicting recovery outcomes in stroke patients, potentially guiding rehabilitation strategies.
How similar studies have performed: While the use of sEMG in stroke recovery prediction is a developing area, similar studies have shown promising results, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients who are hospitalized with upper extremity weakness due to stroke on the same side which confirmed with computed tomography (CT) scan or structural magnetic resonance imaging (MRI), in the acute phase 2. Men and women aged more than 18 years old 3. Willing to participate Exclusion Criteria: 1. Cognitive impairment (MoCA-Ina score less than 26) 2. Impaired consciousness (GCS score less than 15) 3. Unstable medical conditions at time of hospitalization 4. Patients with pacemaker 5. Having other injury or dysfunction in the impaired side of upper extremity that caused restrictions on the range of joint movement and muscle weakness, such as fractures, periarthritis, or moderate-severe pain 6. Diagnosis of other neurological disease or disorders in addition to stroke (e.g., traumatic brain injury, neuropathy or radiculopathy) 7. Get treated in isolation room 8. Hypersensitivity to gel electrodes
Where this trial is running
Bandung, West Java
- Berthy Al Mungiza — Bandung, West Java, Indonesia (RECRUITING)
Study contacts
- Study coordinator: Vitriana Biben, Doctoral
- Email: vitriana@unpad.ac.id
- Phone: 022-7302-931
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Upper Extremity Paresis, Muscle Contracture Upper Arm, Stroke, Surface electromyography, Predictor Stroke, Upper Extremity Recovery